ESC Premium Access

NOACs in cancer associated thrombosis: managing anticoagulation in cancer patients in clinical practice

Event: ESC CONGRESS 2019
Topic: Cardiovascular Disease in Special Populations
Session type: Satellite Symposium
Sponsored by Bayer AG
Date: 1 September 2019
Time: 13:00 - 14:00

Congress Session

5 presentations in this session

Introduction: how NOACs changed the practice in cancer-associated thrombosis

Speaker: Professor S. Konstantinides (Mainz, DE)
Thumbnail

From clinical trial to clinical recommendations: how to apply evidence into practice?

Speaker: Doctor J. Weitz (Hamilton, CA)
Thumbnail

Beyond real word evidence: learnings from databases and registers

Speaker: Associate Professor J. Beyer-Westendorf (Dresden, DE)
Thumbnail

Translating guidelines into clinical practice: when to use NOAC or LMWH?

Speaker: Associate Professor P. Verhamme (Leuven, BE)
Thumbnail

Closing remarks

Speaker: Professor R. Bauersachs (Frankfurt am Main, DE)
Thumbnail

5 speakers from this session

Professor Stavros V Konstantinides

University Medical Center of Mainz, Mainz (Germany)
35 presentations
3 followers

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
20 presentations
0 follower

Associate Professor Jan Beyer-Westendorf

University Hospital "Carl Gustav Carus" Dresden, Center for Vascular Medicine, Dresden (Germany)
5 presentations
0 follower

Associate Professor Peter Verhamme

Gasthuisberg University Hospital, Leuven (Belgium)
9 presentations
0 follower

Professor Rupert Bauersachs

Cardioangiologic Center Bethanien, Frankfurt am Main (Germany)
4 presentations
0 follower

This platform is supported by

logo Novo Nordisk